CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 165 filers reported holding CLOVIS ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -44.4% | 2,000 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | -25.0% | 2,000 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $12,000 | -14.3% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $14,000 | +40.0% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $10,000 | -16.7% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $12,000 | -7.7% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $13,000 | 0.0% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $13,000 | -38.1% | 2,000 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $21,000 | +162.5% | 2,000 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $8,000 | -73.3% | 2,000 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $30,000 | -49.2% | 2,000 | -15.8% | 0.00% | -60.0% |
| Q1 2019 | $59,000 | -39.8% | 2,375 | +14.5% | 0.01% | -54.5% |
| Q4 2018 | $98,000 | +104.2% | 2,075 | +27.7% | 0.01% | +175.0% |
| Q3 2018 | $48,000 | -46.7% | 1,625 | -9.7% | 0.00% | -50.0% |
| Q2 2018 | $90,000 | 0.0% | 1,800 | 0.0% | 0.01% | +14.3% |
| Q1 2018 | $90,000 | -26.2% | 1,800 | 0.0% | 0.01% | -36.4% |
| Q4 2017 | $122,000 | -34.4% | 1,800 | -20.0% | 0.01% | 0.0% |
| Q3 2017 | $186,000 | -11.8% | 2,250 | 0.0% | 0.01% | -21.4% |
| Q2 2017 | $211,000 | -7.9% | 2,250 | -37.5% | 0.01% | 0.0% |
| Q1 2017 | $229,000 | – | 3,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |